| # | Drug | Count |
|---|---|---|
| 0 | LETROZOLE | 243 |
| 1 | LETROZOLE TABLETS | 206 |
| 2 | METHOTREXATE SODIUM | 205 |
| 3 | NATALIZUMAB | 190 |
| 4 | METHOTREXATE | 178 |
| 5 | TRASTUZUMAB | 161 |
| 6 | ERGOCALCIFEROL | 156 |
| 7 | CYCLOPHOSPHAMIDE | 149 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 149 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 149 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM | 3 | 0.1071 |
| 1 | IBANDRONATE SODIUM | 20 | 0.0064 |
| 2 | VINORELBINE | 43 | 0.0062 |
| 3 | ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE | 2 | 0.0054 |
| 4 | ESTERIFIED ESTROGENS, METHYLTESTOSTERONE | 2 | 0.0054 |
| 5 | METEX | 2 | 0.0053 |
| 6 | ERGOCALCIFEROL | 156 | 0.0052 |
| 7 | TOREMIFENE CITRATE | 2 | 0.0046 |
| 8 | PEGFILGRASTIM-JMDB | 2 | 0.0044 |
| 9 | LETROZOLE TABLETS | 206 | 0.0042 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 346 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 248 |
| 2 | Microtubule Inhibitor [EPC] | 241 |
| 3 | Corticosteroid [EPC] | 238 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 238 |
| 5 | Integrin Receptor Antagonist [EPC] | 199 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 178 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 171 |
| 8 | Estrogen [EPC] | 166 |
| 9 | Provitamin D2 Compound [EPC] | 156 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 156 | 0.0052 |
| 1 | Endoglycosidase [EPC] | 9 | 0.0049 |
| 2 | Estrogen Receptor Antagonist [EPC] | 131 | 0.0032 |
| 3 | Aromatase Inhibitor [EPC] | 346 | 0.0030 |
| 4 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 5 | Interleukin-36 Receptor Antagonist [EPC] | 1 | 0.0025 |
| 6 | Integrin Receptor Antagonist [EPC] | 199 | 0.0023 |
| 7 | HER2/neu Receptor Antagonist [EPC] | 171 | 0.0023 |
| 8 | Androgen [EPC] | 40 | 0.0015 |
| 9 | Microtubule Inhibitor [EPC] | 241 | 0.0015 |